MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹529 Cr | ₹459 Cr | ₹339 Cr | ₹259 Cr | ₹340 Cr |
What is the latest Operating Profit of MARKSANS PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹529 Cr |
| Mar2024 | ₹459 Cr |
| Mar2023 | ₹339 Cr |
| Mar2022 | ₹259 Cr |
| Mar2021 | ₹340 Cr |
How is Operating Profit of MARKSANS PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹529 Cr | 15.28 | |
| Mar2024 | ₹459 Cr | 35.15 | |
| Mar2023 | ₹339 Cr | 31.07 | |
| Mar2022 | ₹259 Cr | -23.77 | |
| Mar2021 | ₹340 Cr | - | |
Compare Operating Profit of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,180.3 Cr | 3.1% | 4.2% | -14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3.1% |
4.2% |
-14.2% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses